Armistice Capital, LLC Terns Pharmaceuticals, Inc. Transaction History

Armistice Capital, LLC

  • $6.02 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$4.62 - $10.18 $184,800 - $407,200
-40,000 Reduced 6.67%
560,000 $5.7 Million
Q3 2022

Nov 14, 2022
BUY
$1.87 - $6.42 $517,960 - $1.78 Million
276,984 Added 85.75%
600,000 $3.53 Million
Q2 2022

Aug 15, 2022
BUY
$1.5 - $3.0 $484,524 - $969,048
323,016 New
323,016 $801,000

Others Institutions Holding TERN

# of Institutions
167
Shares Held
78.3M
Call Options Held
580K
Put Options Held
454K
View Full List

About Terns Pharmaceuticals, Inc.

TERN Quotes by TradingView
  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $224M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email